Manufacturer record
Clevus Lifesciences Near Apple Terminal Market: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Clevus Lifesciences Near Apple Terminal Market was declared Not of Standard Quality in June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: UT-969, Albendazole Tablets IP 400mg (exp Aug 2026). RDTL, Hubli, Karnataka (state lab) found it not of standard quality: Test for Dissolution only. Listed in the June 2026 alert.
Records by type
1 record linked to Clevus Lifesciences Near Apple Terminal Market in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Albendazole Tablets IP 400mg | Batch UT-969Mfg Sep 2024 · Exp Aug 2026 | Test for Dissolution onlyDissolution | RDTL, Hubli, KarnatakaState lab | Jun 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.